149 related articles for article (PubMed ID: 29341428)
41. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells.
Ma Y; Hao X; Zhang S; Zhang J
Breast Cancer Res Treat; 2012 Jun; 133(2):473-85. PubMed ID: 21947651
[TBL] [Abstract][Full Text] [Related]
42. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
43. Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
You Y; Li Y; Li M; Lei M; Wu M; Qu Y; Yuan Y; Chen T; Jiang H
Clin Exp Immunol; 2018 Jan; 191(1):60-73. PubMed ID: 28868628
[TBL] [Abstract][Full Text] [Related]
44. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
[TBL] [Abstract][Full Text] [Related]
45. Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
Heise R; Amann PM; Ensslen S; Marquardt Y; Czaja K; Joussen S; Beer D; Abele R; Plewnia G; Tampé R; Merk HF; Hermanns HM; Baron JM
PLoS One; 2016; 11(1):e0146325. PubMed ID: 26735690
[TBL] [Abstract][Full Text] [Related]
46. In situ expression of IFN-gamma-inducible T cell alpha chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression.
Chu Y; Yang X; Xu W; Wang Y; Guo Q; Xiong S
Cancer Immunol Immunother; 2007 Oct; 56(10):1539-49. PubMed ID: 17659370
[TBL] [Abstract][Full Text] [Related]
47. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.
Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O
Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713
[TBL] [Abstract][Full Text] [Related]
48. Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.
Martin-Castillo B; Lopez-Bonet E; Cuyàs E; Viñas G; Pernas S; Dorca J; Menendez JA
Oncotarget; 2015 Oct; 6(32):32317-38. PubMed ID: 26474458
[TBL] [Abstract][Full Text] [Related]
49. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
50. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
[TBL] [Abstract][Full Text] [Related]
51. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate.
Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M
Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093
[TBL] [Abstract][Full Text] [Related]
52. Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells.
Gameiro SR; Malamas AS; Tsang KY; Ferrone S; Hodge JW
Oncotarget; 2016 Feb; 7(7):7390-402. PubMed ID: 26862729
[TBL] [Abstract][Full Text] [Related]
53. Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells.
Yin T; Wang G; He S; Liu Q; Sun J; Wang Y
Cell Immunol; 2016 Feb; 300():41-5. PubMed ID: 26677760
[TBL] [Abstract][Full Text] [Related]
54. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
[TBL] [Abstract][Full Text] [Related]
55. Transcriptomic and epigenetic analysis of breast cancer stem cells.
Li G; Wang D; Ma W; An K; Liu Z; Wang X; Yang C; Du F; Han X; Chang S; Yu H; Zhang Z; Zhao Z; Zhang Y; Wang J; Sun Y
Epigenomics; 2018 Jun; 10(6):765-783. PubMed ID: 29480027
[TBL] [Abstract][Full Text] [Related]
56. Influence of nNav1.5 on MHC class I expression in breast cancer.
Murtadha AH; Azahar IIM; Sharudin NA; Che Has AT; Mokhtar NF
J Biosci; 2021; 46():. PubMed ID: 34313250
[TBL] [Abstract][Full Text] [Related]
57. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.
Salvador MA; Wicinski J; Cabaud O; Toiron Y; Finetti P; Josselin E; Lelièvre H; Kraus-Berthier L; Depil S; Bertucci F; Collette Y; Birnbaum D; Charafe-Jauffret E; Ginestier C
Clin Cancer Res; 2013 Dec; 19(23):6520-31. PubMed ID: 24141629
[TBL] [Abstract][Full Text] [Related]
58. A new strategy using ALDHhigh-CD8+T cells to inhibit tumorigenesis.
Luo H; Zeng C; Fang C; Seeruttun SR; Lv L; Wang W
PLoS One; 2014; 9(8):e103193. PubMed ID: 25105957
[TBL] [Abstract][Full Text] [Related]
59. Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination.
Sharma VP; Tang B; Wang Y; Duran CL; Karagiannis GS; Xue EA; Entenberg D; Borriello L; Coste A; Eddy RJ; Kim G; Ye X; Jones JG; Grunblatt E; Agi N; Roy S; Bandyopadhyaya G; Adler E; Surve CR; Esposito D; Goswami S; Segall JE; Guo W; Condeelis JS; Wakefield LM; Oktay MH
Nat Commun; 2021 Dec; 12(1):7300. PubMed ID: 34911937
[TBL] [Abstract][Full Text] [Related]
60. Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.
Lei MML; Lee TKW
Front Cell Dev Biol; 2021; 9():692940. PubMed ID: 34235155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
